Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR18 Injection in Adults With Overweight or Obesity (Ib/IIa)
CTR20221495Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jun 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bofanglutide in Overweight, obesity, sponsored by Gan & Lee Pharmaceuticals. Started Jun 2022; status: completed.
02
Drugs
bofanglutide
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on CTR20221495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221495.